The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1596
ISSUE1596
April 20, 2020
Intranasal Diazepam (Valtoco) and Midazolam (Nayzilam) for Seizure Clusters
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Intranasal Diazepam (Valtoco) and Midazolam (Nayzilam) for Seizure Clusters
April 20, 2020 (Issue: 1596)
The FDA has approved nasal spray formulations of
the benzodiazepines diazepam (Valtoco — Neurelis)
and midazolam (Nayzilam — UCB) for acute treatment
of intermittent episodes of frequent seizure activity
(seizure clusters). Diazepam rectal...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.